Study of Ceftriaxone and Benzathine Penicillin G During Pregnancy
Public ClinicalTrials.gov record NCT07207876. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase IV Study of the Pharmacokinetics and Safety of Ceftriaxone and Benzathine Penicillin G During Pregnancy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
IMPAACT 2044 is a study to characterize the pharmacokinetics (PK) and safety of ceftriaxone and benzathine penicillin G during pregnancy. Up to 78 pregnant women receiving (1) ceftriaxone for indications other than syphilis or (2) benzathine penicillin G for treatment of syphilis from non-study clinical care providers will be enrolled at study sites located in the United States. Approximately 22 infants of pregnant participants receiving benzathine penicillin G will also be enrolled.
Study identification
- NCT ID
- NCT07207876
- Recruitment status
- Recruiting
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 110 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 15, 2026
- Primary completion
- Jan 14, 2027
- Completion
- Sep 29, 2027
- Last update posted
- Aug 5, 2026
2026 – 2027
United States locations
- U.S. sites
- 8
- U.S. states
- 4
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 5048, USC - Maternal Child Adolescent/Adult Center | Los Angeles | California | 90033 | Recruiting |
| Site 5112, David Geffen School of Medicine at UCLA NICHD CRS | Los Angeles | California | 90095 | Recruiting |
| Site 5083, Rush Univ. Cook County Hosp. Chicago NICHD CRS | Chicago | Illinois | 60612 | Not yet recruiting |
| Site 4001, Lurie Children's Hospital of Chicago (LCH) CRS | Chicago | Illinois | 60614 | Recruiting |
| Site 5040, SUNY Stony Brook NICHD CRS | Stony Brook | New York | 11794 | Recruiting |
| Site 5114, Bronx-Lebanon Hospital Center NICHD CRS | The Bronx | New York | 10457 | Recruiting |
| Site 5013, Jacobi Med. Ctr. Bronx NICHD CRS | The Bronx | New York | 10461 | Recruiting |
| Site 5128, Baylor College of Medicine/Texas Children's Hospital NICHD CRS | Houston | Texas | 77030 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07207876, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 5, 2026 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT07207876 live on ClinicalTrials.gov.